Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

ROLE OF LIPOPROTEIN-LIPASE AND APOLIPOPROTEIN-E SECRETION BY MACROPHAGES IN MODULATING LIPOPROTEIN UPTAKE - POSSIBLE ROLE IN ACCELERATION OF ATHEROSCLEROSIS IN DIABETES 14TH INTERNATIONAL DIABETES FEDERATION SATELLITE SYMP ON MACROVASCULAR COMPLICATIONS OF DIABETES MELLITUS Kraemer, F. B. AMER DIABETES ASSOC. 1992: 77–80

Abstract

Because the accumulation of lipid in macrophages is a characteristic feature of atherosclerosis, the mechanisms by which this lipid accumulation occurs have been intensively studied. This paper reviews the receptor- and non-receptor-mediated pathways that promote lipid accumulation in macrophages. Particular emphasis is placed on the contributions of two secretory products of macrophages, lipoprotein lipase and apolipoprotein E, to both receptor- and non-receptor-mediated uptake of triglyceride-rich lipoproteins by macrophages. The hormonal, lipid, and immunological factors that regulate the secretion of LpL and apoE by macrophages are discussed, as are how changes in the secretion of apoE and LpL that can modulate the uptake of triglyceride-rich lipoproteins by macrophages might influence the atherosclerotic process in people with diabetes.

View details for Web of Science ID A1992JQ02000015

View details for PubMedID 1526341